Survival and functional recovery of transplanted human dopaminergic neurons into hemiparkinsonian rats depend on the cannula size of the implantation instrument

Journal of Neuroscience Methods

Volumn 169, Issue 1, 2008, Pages 128-134

  Steiner, Barbara ^a   Winter, Christine ^a   Blumensath, Stefan ^a   Paul, Gesine ^a   Harnack, Daniel ^a   Nikkhah, Guido ^b   Kupsch, Andreas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cannula size; Human dopaminergic cells; Transplantation

Indexed keywords

OXIDOPAMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANNULATION; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FEMALE; GRAFT SURVIVAL; HUMAN; HUMAN CELL; IMPLANTATION; MESENCHYME CELL; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN TISSUE TRANSPLANTATION; CATHETERIZATION; CELL SURVIVAL; DENERVATION; DISEASE MODELS, ANIMAL; FEMALE; GRAFT SURVIVAL; HUMANS; MESENCEPHALON; MICROSURGERY; NEURONS; NEUROSURGICAL PROCEDURES; NEUROTOXINS; ORGAN CULTURE TECHNIQUES; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; TREATMENT OUTCOME;

EID: 39749112525     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2007.11.032     Document Type: Article

References (35)

1. Abercrombie M. Estimation of nuclear population from microtome sections. Anat Rec 94 (1946) 239-247
2. Barker R.A., and Widner H. Immune problems in central nervous system cell therapy. NeuroRx 1 4 (2004) 472-481
3. Bjorklund A. Cell therapy for Parkinson's disease: problems and prospects. Novartis Found Symp 265 (2005) 174-186
4. Bjorklund A., Stenevi U., Schmidt R.H., Dunnett S.B., and Gage F.H. Intracerebral grafting of neuronal cell suspension. II. Survival and growth of nigral cell suspensions implanted in different brain sites. Acta Physiol Scand Suppl 522 (1983) 9-18
5. Boer G.J. Ethical guidelines for the use of human embryonic or fetal tissue for experimental and clinical neurotransplantation and research. Network of European CNS Transplantation and Restoration (NECTAR). J Neurol 242 1 (1994) 1-13
6. Brandis A., Kuder A., Knappe U., Jodicke A., Schonmayr R., Samii M., et al. Time-dependent expression of donor- and host-specific major histocompatibility complex class I and II antigens in allogeneic dopamine-rich macro- and micrografts: comparison of two different grafting protocols. Acta Neuropathol 95 1 (1998) 85-97
7. Breeze R.E., Wells T.H., and Freed C.R. Implantation of fetal tissue for the management of Parkinson's disease: a technical note. Neurosurgery 36 5 (1995) 1044-1047
8. Brundin P., Nilsson O.G., Strecker R.E., Lindvall O., Astedt B., and Bjorklund A. Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease. Exp Brain Res 65 (1986) 235-240
9. Brundin P., Strecker R.E., Widner H., Clarke D.J., Nilsson O.G., Astedt B., et al. Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: immunological aspects, spontaneous and drug-induced behaviour, and dopamine release. Exp Brain Res 70 1 (1988) 192-208
10. Brundin P., Widner H., Nilsson O.G., Strecker R.E., and Bjorklund A. Intracerebral xenografts of dopamine neurons: the role of immunosuppression and the blood-brain barrier. Exp Brain Res 75 1 (1989) 195-207
11. Brundin P., Pogarell O., Hagell P., Widner H., Schrag A., Kupsch A., et al. Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain 123 (2000) 1380-1390
12. Correia A.S., Anisimov S.Y., Li J.Y., and Brundin P. Stem cell-based therapy for Parkinson's disease. Ann Med 37 (2005) 487-498
13. Duan W.M., Widner H., Frodl E.M., and Brundin P. Immune reactions following systemic immunization prior to intrastriatal transplantation of allogeneic mesencephalic tissue in adult rats. Neuroscience 64 3 (1995) 629-641
14. Elsworth J.D., Brittan M.S., Taylor J.R., Sladek Jr. J.R., al-Tikriti M.S., and Zea-Ponce Y. Restoration of dopamine transporter density in the striatum of fetal ventral mesencephalon-grafted, but not sham-grafted. MPTP-treated Parkinsonian monkeys. Cell Transplant 5 (1996) 315-325
15. Emmett C.J., Jaques B.W., and Seeley P.J. Microtransplantation of neural cells into adult rat brain. Neuroscience 38 (1990) 213-222
16. Farrington M., Wreghitt T.G., Lever A.M., Dunnett S.B., Rosser A.E., and Barker R.A. Neural transplantation in Huntington's disease: the NEST-UK donor tissue microbiological screening program and review of the literature. Cell Transplant 15 4 (2006) 279-294
17. Freed C.R., Green P.E., Breeze R.E., Tsai W.Y., DuMouchel W., Kao R., et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 344 10 (2001) 710-719
18. Hagell P., and Brundin P. Cell survival and clinical outcome following intrastriatal tranplantation in Parkinson disease. J Neuropathol Exp Neurol 60 (2001) 741-752
19. Hagell P., and Cenci M.A. Dyskinesias and dopamine cell replacement in Parkinson's disease: a clinical perspective. Review. Brain Res Bull 68 1-2 (2005) 4-15
20. Jacques D.B., Kopyov O.V., Eagle K.S., Carter T., and Liebermann A. Outcome and complications of fetal tissue transplantation in Parkinson's disease. Stereotact Funct Neurosurg 72 2-4 (1999) 219-224
21. Kordower J.H., Freeman T.B., Snow B.J., Vingerhoets F.J., Mufson E.J., Sanberg P.R., et al. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med 332 (1995) 1118-1124
22. Lindvall O., and Bjorklund A. Transplantation strategies in the treatment of Parkinson's disease: experimental basis and clinical trials. Acta Neurol Scand Suppl 126 (1989) 197-210
23. Mendez I., Hong M., Smith S., Dagher A., and Desrosiers J. Neural transplantation cannula and microinjector system: experimental and clinical experience. Technical note. J Neurosurg 92 3 (2000) 493-499
24. Nikkhah G., Winkler C., Roeter A., and Samii M. In: Dunnett S.B., and Barker G. (Eds). Microtransplantation of nigral dopamine neurons a "step-by-step" recepe. Cell and tissue transplantation in the CNS (2000), Totowa-Humana Press 207-231
25. Nikkhah G., Cunningham M.G., Jodicke A., Knappe U., and Bjorklund A. Improved graft survival and striatal reinnervation by microtransplantation of fetal nigral cell suspensions in the rat Parkinson model. Brain Res 633 1-2 (1994) 133-143
26. Nikkhah G., Olsson M., Eberhard J., Bentlage C., Cunningham M.G., and Bjorklund A. A microtransplantation approach for cell suspension grafting in the rat Parkinson model: a detailed account of the methodology. Neuroscience 63 1 (1994) 57-72
27. Okura Y., Tanaka R., Ono K., Yoshida S., Tanuma N., and Matsumoto Y. Treatment of rat hemiparkinson model with xenogeneic neural transplantation: tolerance induction by anti-T-cell antibodies. J Neurosci Res 48 5 (1997) 385-396
28. Olanow C.W. Surgical therapy for Parkinson's disease. Eur J Neurol 9 Suppl. 3 (2002) 31-39
29. Olanow C.W., Goetz C.G., Kordower J.H., Stoessl A.J., Sossi V., Brin M.F., et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 55 3 (2003) 403-414
30. Paul G., Meissner W., Rein S., Harnack D., Winter C., Hosman K., et al. Ablation of the subthalamic nucleus protects dopaminergic phenotype but not cell survival in a rat model of Parkinson's disease. Exp Neurol 185 2 (2004) 272-280
31. Sauer H., Frodl E.M., Kupsch A., ten Bruggencate G., and Oertel W.H. Cryopreservation, survival and function of intrastriatal fetal mesencephalic grafts in a rat model of Parkinson's disease. Exp Brain Res 90 1 (1992) 54-62
32. Ungerstedt U. Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand Suppl 367 (1971) 69-93
33. Ungerstedt U., and Arbuthnott G.W. Quantitative recording of rotational behaviour in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res 24 3 (1970) 485-493
34. Widner H. The case for neural transplantation as a treatment for Parkinson's disease. Adv Neurol 80 (1999) 641-649
35. Winkler C., Kirik D., and Bjorklund A. Cell transplantation in Parkinson's disease: how can we make it work?. Trends Neurosci 28 (2005) 86-92